Spatial residual disease archetype characterization

sMRD is a platform for deriving 3D tumor bed reconstructions and quantitative features to predict breast cancer relapse risk after neoadjuvant chemotherapy.

How It Works

A streamlined workflow from 2D tissue resection images to 3D MRD representations and spatial pattern risk assessments, designed for clinicians.

Image Preparation

Macroscopy image processing

MRD assessment

Residual disease definition by genomics or pathology

Tumor reconstruction

3D tumor bed rendering

Risk assessment

Relapse predictions based on spatial tumor bed assessment